Click here to go to the previous page
My Big Break: Women At the Top in the Biotechnology Sector
Program Code:
147
Date:
Monday, June 25, 2012
Time:
1:30 PM to 3:00 PM
EST
CHAIR
:
Dr. Mitchell, DIA Annual Meeting Professional Development Track C0-Chair, has special expertise in knowledge management, medical affairs, clinical development, and regulatory intelligence. A family practitioner and ER doctor originally, she trained at Barnes Hospital, LA County, and Mayo Clinic.
|
PRESENTER
(S):
Leslie Williams, ImmusanT, United States
Yvonne Greenstreet, Pfizer Inc, United States
Dr. Carole Sable, an ID physician, joined Merck in 1995 in ID Clinical Research and led the development of Cancidas. In 2007, she became CMO of Novexel and established and was President of the US subsidiary. In 2010, Dr. Sable returned to Merck and is VP Project/Pipeline Leader in Neuroscience.
|
Description
This forum will highlight women who have truly "arrived" as top executives in the biotechnology space, and let you in on how they got to where they are today. Pointers, pitfalls, and the prescriptions for your success will be addressed.
Learning Objectives:
Identify pitfalls and pointers for success
Describe how to stack the deck in your favor when it comes to getting ahead in this challenging environment.